Plus Therapeutics, Inc.

Plus Therapeutics, Inc.verified

PSTV

Price:

$5.01

Market Cap:

$12.12M

Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses. A cornerstone of their pipeline is Rhenium-186 NanoLiposome (R-186 NL), a patented radiotherapy specifically engineered to address difficult central nervous system (CNS) cancers, such as recurrent glioblastoma, leptomeningeal metastases, and various brain cancers affecting children. The company has also secured a licensing agreement with NanoTx, Corp. to advance and commercialize NanoTx's treatment for glioblastoma. Founded in 1996 and headquartered in Austin...[Read more]

Industry

Biotechnology

IPO Date

2001-07-11

Stock Exchange

NASDAQ

Ticker

PSTV

The Current Ratio as of June 2026 (TTM) for Plus Therapeutics, Inc. (PSTV) is 2.27

According to Plus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.27. This represents a change of 49.85% compared to the average of 1.51 of the last 4 quarters.

Plus Therapeutics, Inc. (PSTV) Historical Current Ratio (quarterly & annually)

How has PSTV Current Ratio performed in the past?

The mean historical Current Ratio of Plus Therapeutics, Inc. over the last ten years is 1.30. The current 2.27 Current Ratio has changed 17.35% with respect to the historical average. Over the past ten years (40 quarters), PSTV's Current Ratio was at its highest in in the March 2022 quarter at 4.49. The Current Ratio was at its lowest in in the December 2024 quarter at 0.34.

Quarterly (TTM)
Annual

Average

1.30

Median

1.15

Minimum

0.34

Maximum

3.36

Plus Therapeutics, Inc. (PSTV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Plus Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 264.29%

Maximum Annual Current Ratio = 3.36

Minimum Annual Increase = -63.11%

Minimum Annual Current Ratio = 0.34

Quarterly (TTM)
Annual
YearCurrent RatioChange
20251.23264.29%
20240.34-63.11%
20230.92-50.20%
20221.84-45.22%
20213.36212.72%
20201.07-21.49%
20191.37149.07%
20180.55-31.93%
20170.81-46.17%
20161.50-40.44%

Plus Therapeutics, Inc. (PSTV) Average Current Ratio

How has PSTV Current Ratio performed in the past?

The current Current Ratio of Plus Therapeutics, Inc. (PSTV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

0.83

5-year avg

1.54

10-year avg

1.30

Plus Therapeutics, Inc. (PSTV) Current Ratio vs. Peers

How is PSTV’s Current Ratio compared to its peers?

Plus Therapeutics, Inc.’s Current Ratio is less than NextCure, Inc. (4.61), less than Boundless Bio, Inc. (9.87), less than TAO Synergies Inc. (27.40), less than Q32 Bio Inc. (5.36), greater than Verrica Pharmaceuticals Inc. (2.02), less than AN2 Therapeutics, Inc. (15.73), greater than Jasper Therapeutics, Inc. (2.26), less than Intensity Therapeutics, Inc. (4.86), greater than Iterum Therapeutics plc (2.13), greater than Pluri Inc. (0.33),

Build a custom stock screener for Plus Therapeutics, Inc. (PSTV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Plus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Plus Therapeutics, Inc. (PSTV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Plus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Plus Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Plus Therapeutics, Inc. (PSTV)?

What is the highest Current Ratio for Plus Therapeutics, Inc. (PSTV)?

What is the 3-year average Current Ratio for Plus Therapeutics, Inc. (PSTV)?

What is the 5-year average Current Ratio for Plus Therapeutics, Inc. (PSTV)?

How does the current Current Ratio for Plus Therapeutics, Inc. (PSTV) compare to its historical average?